Oceva 10mg/ml Injection
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Ranibizumab (10mg/ml)
Overview Oceva 10mg/ml Injection
Diabetic retinopathy, macular degeneration, and macular edema are treated with a 10mg/ml Oceva injection. This medication targets abnormal blood vessel growth and leakage in the eye, mitigating vision loss. Administered intraocularly by an ophthalmologist only – self-injection is strictly prohibited. Potential side effects include subconjunctival hemorrhage, ocular pain, floaters, elevated intraocular pressure, and uveitis. Persistent side effects or any concerning symptoms warrant immediate medical consultation. Post-injection, driving is discouraged due to potential visual impairment.
Uses of Oceva 10mg/ml Injection
Retinopathy in diabetes | Neovascular age-related macular degeneration | Macular swelling from retinal vein blockage
Major Benefits of Oceva 10mg/ml Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Oceva 10mg/ml Injection:
- Conjunctival hemorrhage
- Eye pain
- Increased intraocular pressure
- Foreign body sensation in eyes
- Blurred vision
- Nausea
- Dry eye
- Eye itching
- Cataract
- Vitreous floaters
- Vitreous detachment
- Intraocular inflammation
- Eye irritation
- Increased lacrimation
- Eyelid inflammation
- Ocular hyperemia
- Retinal disorder
- Maculopathy
- Eye discomfort
- Posterior capsule opacification
- Injection site hemorrhage
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Anemia (low number of red blood cells)
- Joint pain
- Renal failure
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Gastro-esophageal reflux disease
- Hypercholesterolemia (high cholesterol)
- Bronchitis (inflammation of the airways)
How to use Oceva 10mg/ml Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is not advised.
How Oceva 10mg/ml Injection works:
Oceva 10mg/ml Injection is an anti-angiogenesis agent that inhibits vascular endothelial growth factor (VEGF), thereby preventing the formation and permeability of aberrant ocular blood vessels, which can lead to visual impairment.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Oceva 10mg/ml Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Oceva 10mg/ml Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against possible risks prior to prescribing. Physician consultation is recommended.
Breast feedingSAFE IF PRESCRIBED
Administration of Oceva 10mg/ml Injection while breastfeeding is likely safe. Preliminary human studies indicate minimal risk to the infant.
DrivingUNSAFE
Following administration of Oceva 10mg/ml Injection, temporary blurred vision may occur. Refrain from driving until visual acuity returns to normal.
KidneySAFE IF PRESCRIBED
The use of Oceva 10mg/ml Injection in individuals with impaired kidney function appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, medical advice is recommended.
LiverSAFE IF PRESCRIBED
The use of Oceva 10mg/ml Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates that dosage modification for Oceva 10mg/ml Injection is likely unnecessary in such cases. However, medical advice is recommended.
What if you forget to take Oceva 10mg/ml Injection :
Omitting a dose of Oceva 10mg/ml Injection necessitates contacting your physician.
Facts to Know About Oceva 10mg/ml Injection
| Label | Value |
|---|---|
| Chemical Type | Monoclonal antibody |
| Developing Habits | No. |
| Treatment Category | Ophthalmology |
| Action class | Anti-VEGF therapy for age-related macular degeneration |
3,018 People bought this recently